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OBJECTIVES This study sought to compare computed tomography delayed enhancement (CTDE)
against cardiac magnetic resonance (CMR) late gadolinium enhancement (LGE) for detection of ischemic
scar and to test the additive value of CTDE as part of a comprehensive multidetector computed tomog-
raphy (MDCT) stress–rest protocol including computed tomography perfusion (CTP) and computed to-
mography angiography (CTA) for the diagnosis of signiﬁcant coronary artery disease (CAD).
BACKGROUND CTDE has been recently described as a promising tool for noninvasive detection of
myocardial scar, similarly to CMR-LGE techniques. Despite its theoretical potential as an adjunctive tool to
improve MDCT accuracy for detection of CAD, its clinical performance has not been validated.
METHODS One hundred ﬁve symptomatic patients with suspected CAD (age 62.0  8.0 years, 67%
men) underwent MDCT, CMR, and x-ray invasive coronary angiography. The MDCT protocol consisted of
calcium scoring, stress CTP under adenosine 140 mg/kg/min, rest CTP þ CTA, and a low-dose radiation
prospective scan for detection of CTDE. CMR-LGE was used as the reference standard for assessment
of scar. Functionally signiﬁcant CAD was deﬁned as the presence of $90% stenosis/occlusion or frac-
tional ﬂow reserve measurements #0.80 in vessels >2 mm.
RESULTS CTDE had good accuracy (90%) for ischemic scar detection with low sensitivity (53%) but
excellent speciﬁcity (98%). Positive and negative predictive values were 82% and 91%, respectively.
On a patient-based model, MDCT protocol without integration of CTDE results had a sensitivity, speci-
ﬁcity, and positive and negative predictive values of 90%, 81%, 80%, and 90%, respectively, for the detec-
tion of functionally signiﬁcant CAD. Addition of CTDE results did not improve MDCT performance (90%,
77%, 77%, and 90%, respectively).
CONCLUSIONS CTDE has moderate accuracy for detection of ischemic scar in patients with sus-
pected CAD. Integration of CTDE into a comprehensive MDCT protocol including stress–rest CTP and
CTA does not improve MDCT accuracy for detection of signiﬁcant CAD in intermediate-to-high pre-
test probability populations. (J Am Coll Cardiol Img 2013;6:1062–71) ª 2013 by the American College
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1063ultidetector computed tomography
(MDCT) coronary angiography repre-
sents the noninvasive gold standard for
the assessment of the coronary arterial
tree. It is particularly useful for the exclusion
of coronary artery disease (CAD) in patients
with intermediate/low pre-test probability, largely
because of its high negative predictive value (1).
However, in patients with higher pre-test proba-
bility, its performance is limited because the
physiological signiﬁcance of many lesions cannot
be assessed (2). To overcome this limitation,See page 1072
A B B R E V I A T I O N S
A N D A C R O N YM S
CAD = coronary artery disease
CI = conﬁdence interval
CMR = cardiac magnetic
resonance
CTA = computed tomography
angiography
CTDE = computed tomography
delayed enhancement
CTP = computed tomography
perfusion
FFR = fractional ﬂow reserve
LGE = late gadolinium
enhancement
MDCT = multidetector
computed tomography
QCA = quantitative coronary
angiography
ROC = receiver-operating
characteristic
XA = x-ray invasive coronary
raphyMDCT stress–rest myocardial perfusion techniques
(computed tomography perfusion [CTP]) have been
described (3–6), and integrated protocols, providing
both morphological (computed tomography angiog-
raphy [CTA]) and functional (CTP) information in a
single MDCT exam, have been tested (7–13).
MDCT ability to identify myocardial ischemic scar
using computed tomography delayed enhancement
(CTDE) has also been reported. This technique fol-
lows the same principles applied to cardiovascular
magnetic resonance (CMR) late gadolinium enhance-
ment (LGE) and could be particularly valuable as part
of a MDCT protocol including CTA and CTP. The
feasibility of performing such a comprehensive exami-
nation has already been shown, but CTDE’s potential
as an adjunctive tool to improve MDCT accuracy for
the detection of CAD has never been validated (14).
The aim of this study was to evaluate the diagnostic
performance of low-radiation-dose CTDE for
detection of ischemic scar using CMR-LGE as the
standard and to test the additive value of CTDE as
part of an comprehensiveMDCTprotocol, including
CTA and stress–rest CTP, for the diagnosis of
functionally signiﬁcant CAD, using invasive x-ray
coronary angiography (XA) with fractional ﬂow
reserve (FFR) evaluation as the reference standard.
METHODS
Population. We prospectively screened 176 con-
secutive patients with suspected CAD referredreceived grant support from the Portuguese Society of Cardiology and the Eur
support from the British Heart Foundation (FS/10/029/28253; RE/08/003)
Chiribiri was funded by the Wellcome Trust and Engineering and Physical Sc
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Manuscript received January 16, 2013; revised manuscript received April 5, 2by general physicians to our hospital outpatient
cardiology clinic from February 2010 to November
2011. Inclusion criteria were age >40 years, symp-
toms compatible with CAD, and at least 1 of
the following: $2 risk factors or a positive/incon-
clusive treadmill test. Exclusion criteria included
unstable clinical status, known CAD, valvular heart
disease, atrial ﬁbrillation, creatinine clearance
#60 ml/min, and standard contraindications to
CMR, contrast media, and adenosine. A total of
139 eligible patients were tested for exclusion
criteria. Figure 1 summarizes the study ﬂow and
reasons for exclusions. Characteristics of the ﬁnal
population are summarized in Table 1.
Study design. After informed consent, patients
were scheduled for CMR and MDCT in
the week before XA. FFR was measured in
all major patent epicardial coronary arteries
with intermediate diameter stenoses (50%
to 90%) as assessed by quantitative coro-
nary angiography (QCA). CMR and
MDCT results were fully blinded.
CMR protocol. CMR was performed using
established protocols on a 1.5-T Siemens
Symphony Tim (Siemens, Erlangen, Ger-
many) using a 12-channel receiver coil (15).
Long- and short-axis cine images were ob-
tained using a steady-state free precession
breath-hold sequence for volumetric and
functional analysis. LGE imaging was per-
formed using a 2-dimensional phase-
sensitive inversion-recovery breath-hold
sequence $10 min after administration of
contrast (0.2 mmol/kg). The entire volume
of the heart was covered in 8-mm-thick
short-axis projections with a gap of 2 mm
between slices, and in standard long-axis
cardiac planes.
MDCT comprehensive protocol. MDCT stress–rest
protocol was performed as previously published,
with the addition of a low-radiation scan for CTDE
detection (Fig. 2) (8). All scans were performed
using a Somatom Sensation 64 scanner (Siemens
Medical Solutions, Forchheim, Germany) with no
pre-test medication. The comprehensive MDCT
protocol included 4 sequential acquisitions: calcium
scoring, stress CTP, rest CTP, and CTDE. Table 2
angiogopean Society of Cardiology. Dr. Schuster acknowledges grant
and the Biomedical Research Centre (BRC-CTF 196). Dr.
iences Research Council under grant number WT 088641/Z/
s received grant support from Philips Healthcare and Bayer
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Figure 1. Study Flowchart and Reasons for Exclusions
CAD ¼ coronary artery disease; CI ¼ conﬁdence interval; CMR ¼ cardiac magnetic resonance; CTDE ¼ computed tomography delayed
enhancement; MDCT ¼ multidetector computed tomography; pts ¼ patients.
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1064summarizes the scan parameters of each portion of
the protocol.
First, a low-dose prospective scan to assess coro-
nary artery calciﬁcation was performed using estab-
lished protocols (16). Then, adenosine infusion (140
mg$kg1$min1 for 3 to 6 min) was started, and a
retrospectively gated scan was acquired during the
ﬁrst passage of contrast medium, using a bolus-
tracking technique. Adenosine infusion was dis-
continued immediately after stress acquisition.
Intravenous metoprolol targeting a heart rate
#60 beats/min was administered in patients whose
heart rate exceeded 65 beats/min 3 min after the
suspension of the adenosine infusion. All patients
received 0.5 mg of sublingual nitroglycerin before the
rest scan. The latter was acquired 10 min after the
ﬁrst contrast injection, using prospective triggering.
Timing and contrast administration were similar to
the stress scan, using a test-bolus technique. To
detect areas of CTDE, a fourth scan was performed
7.0  0.3 min after the rest scan using prospective
triggering at 65% of the RR interval. For this
acquisition, a ﬁxed tube voltage of 80 kV and a tube
current of 160 mA were used, and collimation wasincreased to 1.2 mm. No additional contrast was
administered.
CMR analysis. Two blinded independent readers
analyzed all CMR images. In cases of disagreement,
a third reader adjudicated. Each of the 17 segments
was classiﬁed on the basis of the presence and
transmurality (subendocardial vs. transmural) of
scarddeﬁned as areas of myocardial enhancement
using LGE imaging. Ischemic scar was assumed
when subendocardial involvement was noted. Image
quality and the degree of conﬁdence in scar detec-
tion were classiﬁed independently using 4-class (0 to
3) scales: from poor to excellent and from very
unconﬁdent to very conﬁdent, respectively.
MDCT analysis. MDCT images were analyzed using
dedicated software (Aquarius Intuition version
4.4.6, TeraRecon, Foster City, California) on
dedicated workstations by 2 independent blinded
readers. Each component of the MDCT scan was
analyzed independently at a different time point of
the study.
Coronary calciﬁcation was calculated using an
effective slice thickness of 3 mm with a detection
threshold of 130 HU and reported as the mean
Table 1. Patient Characteristics, N [ 105
Male 70 (67)
Age, yrs 62  8.0 (41–79)
Body mass index, kg/m2 27.9  4.43 (19.9–45.2)
Symptoms 105 (100)
Typical angina 27 (26)
Atypical angina 50 (48)
Chest pain 23 (22)
Dyspnea on exertion/fatigue 5 (5)
Hypercholesterolemia 83 (79)
Hypertension 75 (71)
Diabetes mellitus 40 (38)
Positive smoking history 34 (32)
Current smoker 14 (13)
Ex-smoker 20 (19)
Family history of premature CAD 21 (20)
$2 Cardiovascular risk factors 88 (84)
Systolic blood pressure, mm Hg 149  22.9 (99–184)
Diastolic blood pressure, mm Hg 79  10.7 (57–102)
Abdominal circumference, cm 98  10.8 (76–126)
Modiﬁed Diamond-Forrester score 14.2  2.60 (9–20)
On regular medication 93 (89)
Aspirin or clopidogrel 56 (53)
Statin 66 (63)
ACEi or A2 receptor blockers 51 (49)
Beta-blocker 38 (36)
Agatston calcium score 280 (0, 5,879)
#10 19 (18)
11–100 21 (20)
101–400 18 (17)
401–1,000 27 (26)
>1,000 19 (18)
Any stenosis $50% 59 (56)
Any functionally signiﬁcant stenosis 48 (46)
Single-vessel disease 24 (23)
Double-vessel disease 16 (15)
Triple-vessel disease 8 (8)
Left main disease 5 (5)
Values are n (%), mean  SD (95% conﬁdence interval), or median (minimum,
maximum).
ACEi¼ angiotensin-converting enzyme inhibitor; A2 ¼ angiotensin 2; CAD¼
coronary artery disease.
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1065Agatston score. For CTA and CTP analysis, both
stress and rest acquisitions were evaluated using sets
of 11 retrospective phases from the stress scan, and
a single-phase (65%) reconstruction from the rest
scan (8). Soft (Siemens-B25f) and very smooth
(Siemens-B10f) frequency ﬁlters were used for CTA
and CTP reconstructions, respectively. ResultingCTA datasets were analyzed for detection of CAD
according to the 17-segment modiﬁed American
Heart Association classiﬁcation (17). On the basis of
the information obtained from both stress and rest
reconstructions, each segment was graded, accord-
ing to stenoses: 1 ¼ normal, 2 ¼ <50%, 3 ¼ 50% to
70%, 4 ¼ $70%/occlusion, 5 ¼ uninterpretable.
Analysis of CTP was performed according to the
standard 17-segment model, using 10-mm-thick
multiplanar reformat planes (short-axis and 2, 3, and
4 chambers) (18). Stress images were analyzed as
cines, integrating perfusion with regional wall mo-
tion information and compared with rest.
For CTDE analysis, a 65% single-phase recon-
struction was obtained using a very smooth ﬁlter
(Siemens-B10f) and a slice thickness of 1.2 mm.
Reading was performed using the same multiplanar
reformat planes and reporting model (18). It was
typically initiated using 10-mm-thick average in-
tensity projections, and set, by protocol, to narrow
window and level settings (W300, L150). The
reading physician was allowed to adjust these display
settings after an initial exploratory reading, and to
change slice thickness and projections as needed.
Each of the 17 segments was classiﬁed based on the
presence and transmurality (subendocardial vs.
transmural) of CTDE, deﬁned as areas of myocar-
dial enhancement when compared with remote re-
gions of the myocardium. Readers were asked to
determine whether ischemic scar was present and to
classify image quality and degree of conﬁdence, as
described for CMR. Interobserver disagreements
were resolved by consensus. Signal-to-noise ratio
(mean signal intensity/standard deviation of signal
intensity) of the CTDE scan was estimated using a
10-mm2 region of interest in the left ventricle.
MDCT RADIATION EXPOSURE ESTIMATION. Effec-
tive radiation dose exposure for each component of
the MDCT comprehensive protocol (calcium score,
stress CTA/CTP, rest CTA/CTP, and CTDE)
was calculated by the method proposed by the Eu-
ropean Working Group for Guidelines on Quality
Criteria in CT: product of the chest coefﬁcient
(0.014) and the dose-length product obtained dur-
ing each scan (19).
XA and FFR assessment. XA was performed ac-
cording to standard techniques. Excluding the left
main, arteries with a caliber>2mm and intermediate
stenosis (diameter stenosis $50% and <90%) as
assessed by QCA (Siemens Leonardo XP, Siemens
AG, Munich, Germany, and IC3D v1.6.8.83A
software, PaieonMedical, Rosh Ha’ayin, Israel) were
evaluated using pressure wire (PressureWire Certus,
Figure 2. Simpliﬁed Scheme of MDCT Protocol
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1066St. Jude Medical, St. Paul, Minnesota). FFR was
determined by RadiAnalyzer (St. Jude Medical) un-
der steady-state hyperemia, obtained with intrave-
nous adenosine (140 mg/kg/min) infusion over 3 to 6
min. Arteries were recorded as having signiﬁcant
ﬂow-limiting disease if they had stenoses $90%
($50% in the left main stem) or had a FFR value
#0.80 in vessels >2 mm.
Statistical analysis. CTDE per-patient performance
for the detection of ischemic scar was tested against
CMR-LGE as the reference standard. The poten-
tial value of integrating CTDE with the combined
CTA þ CTP analysis was also tested as an additive
tool to increase MDCT performance for the
detection of functionally signiﬁcant CAD as
assessed by XA þ FFR. The diagnostic perfor-
mances of each component of MDCT (CTA,
CTP, and CTDE), as well as the integration
of CTA þ CTP (integrated protocol) and
CTA þ CTP þ CTDE (comprehensive protocol)
were compared against XA þ FFR as the reference
standard. Ninety-ﬁve percent conﬁdence intervals
(CI) were calculated based on the binominal dis-
tribution. “Nonevaluable” coronary segments in
CTA were coded as being positive for CAD when
CTA alone was considered; in the integrated pro-
tocol, they were classiﬁed as negative or positive for
functionally signiﬁcant CAD, according to the CTP
results of their territory. In the comprehensive pro-
tocol, these vessels were coded positive if scar was
detected in the corresponding territory; if not, theywere coded according to the CTP results, similar to
the integrated protocol (Fig. 3). CMR-LGE and
CTDE intraobserver and interobserver agreements
were tested using Cohen’s kappa statistic.
All data are described as means and standard de-
viations for continuous variables and as percentages
for categorical variables. Differences in continuous
variables were assessed using Student paired t tests.
The area under the receiver-operating characteristic
(ROC) curve was calculated for all diagnostic-testing
strategies using XA þ FFR assessment as the gold
standard. A p value<0.05was considered signiﬁcant.
Data analysis was performed using SPSS analysis
software (Release 17, SPSS, Chicago, Illinois).
Ethics. The study protocol was approved by the
local research ethics committee and complies with
the Declaration of Helsinki. Written informed
consent was obtained from all participants.
RESULTS
The ﬁnal population consisted of 105 symptomatic
individuals (age 62  8 years; 67% men) with an
intermediate or high pre-test probability according
to the modiﬁed Diamond-Forrester score (20).
All CMR and MDCT scans were performed
within 9.0  7.7 days before XA, and all patients
completed the study protocol without adverse effects.
CMR scans. Myocardial LGE was visualized in
24 patients; 17 of those had an ischemic pat-
tern (Fig. 4). In 7, however, an intramural/
(Ischemia) Ischemia)
Figure 3. MDCT Comprehensive Protocol Interpretative Algorithm
CTA ¼ computed tomography angiography; CTP ¼ computed tomography
perfusion; other abbreviations as in Figure 1.
Table 2. MDCT Scan Details
Days from MDCT to XA 4.8  4.62 (1–29)
Total volume of contrast used, ml 182  14.2 (120–215)
Stress scan 80  6.6 (50–110)
Rest scan 84  8.8 (50–110)
Effective radiation, total, mSv 5.5  0.95 (3.9–9.9)
Effective radiation stress scan 3.3  0.48 (2.4–5.2)
Effective radiation rest scan 1.0  0.71 (0.2–3.7)
Effective radiation CAC scan 0.5  0.24 (0.3–2.2)
Effective radiation CTDE scan 0.5  0.10 (0.1–0.7)
Stress–rest delay, min 17  9.0 (7–49)
Rest–CTDE delay, min 7  0.3 (6–8)
Heart rate
Stress, beats/min 76  15.6 (44–118)
Rest, beats/min 63  7.1 (48–81)
Late enhancement 63  7.3 (47–84)
Values are mean  SD (95% conﬁdence interval).
CAC ¼ coronary artery calciﬁcation; CTDE ¼ computed tomography delayed
enhancement; MDCT ¼ multidetector computed tomography; XA ¼ x-ray
coronary invasive angiography.
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 6 , N O . 1 0 , 2 0 1 3 Bettencourt et al.
O C T O B E R 2 0 1 3 : 1 0 6 2 – 7 1 CT Delayed Enhancement for Ischemic Scar
1067subepicardial pattern was detected. Intraobserver
and interobserver agreements for ischemic scar
detection were very good (kappa ¼ 0.77 and 0.66,
respectively).
MDCT scans. Among the 105 CTA examinations,
33 (31%) had at least 1 nonevaluable segmentd
usually because of the presence of extensive calciﬁ-
cation. Among the patients who had fully inter-
pretable scans, 10 had no atherosclerotic disease,
24 had mild disease (<50% stenosis), and 38
had signiﬁcant stenosis ($50%). When the non-
evaluable segments were considered to represent
disease, 71 (68%) patients were categorized as
having signiﬁcant CAD. CTP defects were identi-
ﬁed in 38 patients (36%) and in 53 (17%) vascular
territories.
Myocardial CTDE was described in 13 patients
(12%), including 2 with a nonischemic pattern.
Frequently, areas of CTDE had the same density as
the blood pool, appearing in the short-axis plane as
complete or subendocardial interruptions of the
circular shape of the myocardium (Fig. 4). Of the
11 patients with an ischemic CTDE pattern, 9 had
evidence of perfusion defects on rest CTP, whereas
2 were normal. The CTDE image quality of most of
the scans was classiﬁed as good (57) or excellent
(27), and only 1 scan was classiﬁed as poor. Readers
felt conﬁdent or very conﬁdent in the vast majority
of cases (62 or 31 cases, respectively); moderately
low conﬁdence was reported in 12 cases. Compared
with the scans of patients weighing #80 kg, CTDEscans of patients >80 kg had a lower signal-to-noise
ratio (5.3  2.23 vs. 7.3  2.65; p ¼ 0.003), worse
image quality (1.6  0.61 vs. 1.9  0.64; p ¼ 0.03),
and lower reported conﬁdence (1.8  0.52 vs.
2.04  0.51; p ¼ 0.02).
Mean radiation exposure of the entire MDCT
protocol was 5.5  0.95 mSv (3.9 to 9.9 mSv). The
CTDE scan was responsible for only 0.50  0.10
mSv of radiation exposure. Estimated effective ra-
diation exposure for each component of the MDCT
protocol is described in Table 2. Good reproduc-
ibility of CTDE analysis was found, with very good
intraobserver (kappa ¼ 0.78) and interobserver
agreement (kappa ¼ 0.76).
XA and FFR results. Seventy patients had some
degree of coronary stenosis on visual analysis and
were evaluated using QCA: of those, 59 had ste-
nosis $50%, including 20 with total occlusions.
Nineteen patients with intermediate stenosis in
vessels >2 mm were evaluated by FFR. Using this
approach, a total of 48 patients were classiﬁed as
having functionally signiﬁcant CAD: single-vessel
disease was seen in 24 patients, 16 had double-
vessel disease, and 8 had triple-vessel disease.
Left main disease was found in 5 of these patients.
Figure 4. Two Cases Illustrating CMR-LGE, CTDE, and Angiographic Findings in
Patients With Ischemic Scar
(A) A 67-year-old woman, with typical chest pain, diabetes, and hypertension. Late gado-
linium enhanced (LGE) CMR shows subendocardial hyperenhancement in the mid and
distal segments of the anterior and anteroseptal wall and in the anterolateral basal seg-
ments (arrows). CTDE images are concordant, showing abnormal myocardial intensity in
the same areas (similar to the blood pool). Angiography revealed a chronically occluded
proximal left descending artery and a subtotally occluded marginal coronary artery
(arrowheads). (B) A 54-year-old man with diabetes, hypertension, and dyslipidemia
complaining of typical chest pain. LGE CMR shows subendocardial inferolateral infarction in
the mid and basal segments (arrows). CTDE ﬁndings are concordant. Triple-vessel disease
was detected on x-ray invasive coronary angiography with signiﬁcant left main disease, and
severe proximal stenosis on the left descending and circumﬂex coronary arteries
(arrowheads). Abbreviations as in Figure 1.
Table 3. Patient-Base
CTDE
Weight #80 kg
Weight >80 kg
Heart rate <63 beats/
Heart rate $63 beats/
Accu. ¼ accuracy; CAD ¼
value; LGE ¼ late gadolini
Specif. ¼ speciﬁcity; TN ¼
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1068CTDE performance for ischemic scar detection using
CMR-LGE as a reference. CTDE accurately detected
ischemic scar in 9 of 17 patients identiﬁed by CMR.
On a per-patient level, CTDE had good accuracy
(90%) for ischemic scar detection with low sensi-
tivity (53%) but excellent speciﬁcity (98%). CTDE
performed better in patients weighting #80 kg and
was not signiﬁcantly affected by heart rate during
acquisition (Table 3).d Analysis of CTDE in Predicting LGE on CMR
CAD (%) n TP TN FP FN k Sensit. (%) Sp
16.2 105 9 86 2 8 0.59 53 (33–63) 98
16.7 72 8 60 0 4 0.77 67 (43–67) 100
15.2 33 1 26 2 4 0.15 20 (1–52) 93
min 10.2 49 2 42 2 3 0.39 40 (8–71) 95
min 10.3 58 3 50 2 3 0.50 50 (15–76) 96
coronary artery disease; CMR ¼ cardiac magnetic resonance; CTDE ¼ computed tomog
um enhancement; þLR ¼ positive likelihood ratio; LR ¼ negative likelihood ratio; PPV
true negative; TP ¼ true positive.Patient-based analysis. MDCT performances for
detection of functionally signiﬁcant CAD are
summarized in Table 4. Isolated CTA analysis had
an excellent sensitivity and negative predictive value
(100%). However, speciﬁcity and positive predictive
value were low (60% and 68%, respectively). CTP,
conversely, had higher speciﬁcity (93%), at a cost of
lower sensitivity (71%). The integration of data
from CTA and CTP resulted in a sensitivity of 90%
and speciﬁcity of 81%. Addition of scar information
as detected by CTDE (CTA þ CTP þ CTDE)
(Fig. 3) did not improve overall MDCT accuracy
(sensitivity 90%, speciﬁcity 77%).
ROC analysis. The ROC analysis for the prediction
of functionally signiﬁcant CAD is represented in
Figure 5. The areas under the curve for signiﬁcant
CAD detection were 0.80 (95% CI: 0.71 to 0.89)
for CTA alone, 0.82 (95% CI: 0.73 to 0.91)
for CTP alone, 0.58 (95% CI: 0.47 to 0.69) for
CTDE alone, 0.85 (95% CI: 0.77 to 0.93) for the
CTA þ CTP integrated protocol, and 0.83 for the
comprehensive protocol, including analysis of
CTDE (95% CI: 0.75 to 0.92).
D I SCUSS ION
The main ﬁndings of our study are that: 1) low-
radiation CTDE performed immediately after a
stress–rest MDCT protocol is capable of scar
detection with reasonable accuracy but low sensi-
tivity; and 2) the addition of CTDE to a stress–rest
CTA þ CTP integrated protocol does not improve
the global accuracy of MDCT for the detection of
functionally signiﬁcant CAD in patients with
intermediate-to-high pre-test probability.
We and others have previously shown that
integration of CTP with CTA improved diagnostic
accuracy of MDCT in patients with intermediate-
to-high pre-test probability, mainly because of an
increased speciﬁcity in heavily calciﬁed coronary
arteries (7–12). In this study, we added CTDEecif. (%) PPV (%) NPV (%) DLR LLR Accu. (%)
(94–100) 82 (51–97) 91 (88–93) 23.29 0.48 90 (84–94)
(95–100) 100 (65–100) 94 (89–94) d 0.33 94 (86–94)
(90–99) 33 (2–86) 87 (84–92) 2.80 0.86 82 (76–91)
(92–99) 50 (10–89) 93 (90–97) 8.80 0.63 90 (83–96)
(92–99) 60 (19–92) 94 (90–97) 13.00 0.52 91 (84–97)
raphy delayed enhancement; FN ¼ false negative; FP ¼ false positive; k ¼ kappa
¼ positive predictive value; NPV ¼ negative predictive value; Sensit. ¼ sensitivity;
Table 4. Patient-Based Analysis of MDCT Protocol in Predicting Functionally Signiﬁcant CAD
CAD (%) n TP TN FP FN k Sensit. (%) Specif. (%) PPV (%) NPV (%) DLR LLR Accu. (%)
CTA alone 45.7 105 48 34 23 0 0.58 100 (92–100) 60 (53–60) 68 (62–68) 100 (89–100) 2.48 0.00 78 (71–78)
CTP alone 45.7 105 34 53 4 14 0.65 71 (61–76) 93 (85–98) 89 (77–96) 79 (72–83) 10.09 0.31 83 (74–88)
CTDE 45.7 105 8 54 3 40 0.12 17 (9–21) 95 (89–99) 72 (41–93) 57(54–60) 3.17 0.88 59 (52–63)
CTA þ CTP Integ. Prot. 45.7 105 43 46 11 5 0.70 90 (80–96) 81 (72–86) 80 (71–85) 90 (81–96) 4.64 0.13 85 (76–90)
CTA þ CTP þ CTDE Comp. Prot. 45.7 105 43 44 13 5 0.66 90 (80–96) 77 (69–82) 77 (68–82) 90 (80–96) 3.93 0.13 83 (74–89)
Comp. Prot. ¼ comprehensive protocol; CTA ¼ computed tomography angiography; CTP ¼ computed tomography perfusion; Integ. Prot. ¼ integrated protocol; other abbreviations as in Tables 2
and 3.
Figure 5. ROC Curves
CTA, CTP, CTDE, and the integrated (CTA þ CTP) and compre-
hensive (CTA þ CTP þ CTDE) protocols as predictors of function-
ally signiﬁcant CAD. AUC ¼ area under the curve; ROC ¼ receiver-
operating characteristics; other abbreviations as in Figures 1 and 3.
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1069analysis to our integrated CTA þ CTP protocol,
aiming to test its potential as an additive tool for the
diagnosis of CAD. A similar approach has been
proposed for CMR using LGE to improve the ac-
curacy of stress perfusion, but currently, this algo-
rithm is seldom used (21).
In our study, ischemic scar was documented in a
signiﬁcant proportion of patients using CMR-
LGE; however, CTDE was only able to detect
about one-half of those cases. Furthermore, the
addition of CTDE to the integrated protocol
including CTA and CTP did not improve MDCT
performance for the detection of functionally sig-
niﬁcant CAD; this occurred because the majority of
patients with ischemic scar also had reversible de-
fects compatible with ischemia (already detected as
positives) and because some patients had ischemic
scar with normal coronary arteries. Inclusion of
CTDE into the comprehensive MDCT protocol
had a limited, but positive, impact because ischemic
scar was detected in 2 patients with normal arteries
and no perfusion defect on rest CTP. However, the
potential advantage of a better prognostic and
therapeutic management has to be balanced against
the extra time needed for the CTDE scan and ra-
diation exposure.
Only 1 previous study analyzed CTDE in the
context of a comprehensive MDCT protocol, in-
cluding CTA and stress/rest CTP: the ﬁnal popu-
lation of 34 patients was selected from those who
underwent a nuclear stress test and XA within 3
months, including a signiﬁcant proportion of pa-
tients with known CAD (14). Integration of CTDE
did not improve MDCT ability to detect CAD, as
deﬁned by stenosis $70%. Differently from Blank-
stein et al. (14), we only included intermediate/high
pre-test probability symptomatic patients without
known history of CAD and used FFR as the refer-
ence standard. Additionally, CMR-LGE was used
as the standard to individually evaluate CTDE per-
formance in scar detection. The entire MDCTcomprehensive protocol, including CTA, CTP, and
CTDE, was completed with an effective radiation
exposure that represents less than one-half of the
exposure usually reported for nuclear studies. The
CTDE acquisition represents a very small proportion
of that value, being responsible for an average radi-
ation exposure of as low as 0.5  0.1 mSv.
CMR has the unique capability of scar detection
using LGE techniques, which allow an optimized
contrast between scar and myocardium. Iodinated
contrast agents used in MDCT have similar kinetics
to the gadolinium chelates used in CMR (22).
Thus, images acquired 4 to 30 min after contrast
administration may show regional hyperenhance-
ment, corresponding to areas of myocardial scar,
similar to CMR-LGE (23–25). Despite no
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1070consensus regarding the optimal protocol for
contrast administration and timing of CTDE im-
aging, our methods are in line with previous studies.
Contrast doses of 120 to 150 ml or 2 ml/kg and
delay times ranging from 5 to 15 min after contrast
material injection have been described (25,26).
Differently from CMR-LGE, where the contrast
may be optimized using speciﬁc inversion times
selected to null the normal myocardium, CTDE has
to rely on different tones of gray, corresponding
to different Hounsﬁeld units, according to the
different degrees of radio-opacity of the tissues.
CTDE areas do not appear as highly contrasted
bright zones surrounded by dark myocardium. In
fact, in our population, CTDE was most commonly
detected as segmental areas where the myocardium
could no longer be deﬁned and differentiated from
the gray area corresponding to the blood pool. Vi-
sual detection of those areas may be difﬁcult, espe-
cially when slight subendocardial involvement is
present; this may explain the relatively low sensi-
tivity when compared to CMR. Furthermore, it has
been suggested that the use of a low-dose approach
by setting tube voltage to 80 kV, despite the
intrinsic advantage of better signal-to-noise and
contrast-to-noise ratios (27–30), may be associated
with an insufﬁcient image quality, especially in
obese patients (30,31). In this context, Habis et al.
(32) proposed a strategy of tube voltage adjustment
according to weight (80 kV for patients #80 kg and
100 kV for patients weighting >80 kg). Our results
seem to support this strategy because image quality,
readers’ conﬁdence, and CTDE diagnostic perfor-
mance for detection of scar were lower in patients
weighting >80 kg.
Study limitations. In this single-center study, only
symptomatic patients without known CAD and
an intermediate-to-high pre-test probability wereincluded. A small percentage of patients had to be
excluded because of contraindications, such as renal
dysfunction or arrhythmia. As such, these results may
not apply to other groups of patients referred for CTA.
FFR was only measured in vessels with intermediate
stenosis on QCA assessment. Stenoses with QCA
<50% were assumed to be irrelevant, and stenoses
$90% were considered functionally signiﬁcant.
Although this was performed to avoid potential iatro-
genic complications, and reﬂects current clinical prac-
tice in many centers, it may lead to a small bias.
Another limitation concerning study design is the
performance of 2 contrasted scans a few minutes apart:
this assures clinical applicability but is associated with
some drawbacks related to contrast redistribution and
optimization of heart rate for the CTA scan. Further-
more, CTDE was tested using a very low radiation
protocol without the use of any additional contrast.
Despite the appeal of this approach, because it could be
easily implemented in a comprehensive MDCT pro-
tocol without increase of patient risks, it is possible that
CTDE could be optimized using different parame-
tersdnamely higher tube current and current intensity
or dedicated injections of higher doses of contrastdas
the ideal CTDE protocol is still under research. Post-
processing software may also be an important tool for
optimizing scar detection using MDCT. Nevertheless,
our study shows that CTDE integration into aMDCT
comprehensive protocoldusing commercially standard
and widely available software and hardwaredis feasible
and may inform about the presence of scar in patients
with suspected CAD.Reprint requests and correspondence: Dr. Nuno Betten-
court, Cardiology Department, Centro Hospitalar de Vila
Nova de Gaia/Espinho EPE, Rua Conceição Fernandes,
4434-502 Vila Nova de Gaia, Portugal. E-mail:
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